PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia

Blinatumomab is an efficacious immunotherapeutic agent in B cell acute lymphoblastic leukemia (B-ALL). However, the pharmacogenomic basis of leukemia response to blinatumomab is unclear. Using genome-wide CRISPR, we comprehensively identified leukemia intrinsic factors of blinatumomab sensitivity, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yizhen, Moriyama, Takaya, Yoshimura, Satoshi, Zhao, Xujie, Li, Zhenhua, Yang, Xu, Paietta, Elisabeth, Litzow, Mark R., Konopleva, Marina, Yu, Jiyang, Inaba, Hiroto, Ribeiro, Raul C., Pui, Ching-Hon, Yang, Jun J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750140/
https://www.ncbi.nlm.nih.gov/pubmed/36516256
http://dx.doi.org/10.1126/sciadv.add6403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750140/
https://www.ncbi.nlm.nih.gov/pubmed/36516256
http://dx.doi.org/10.1126/sciadv.add6403

Ejemplares similares